WASHINGTON - ESI Lederle announced last Thursday that it was recalling 4.2 million capsules of the arthritis drug etodolac because of contamination that could cause life-threatening complications in patients with heart conditions.
The company said that the recall will cover one lot of 300-milligram capsules, No. 9991052, which were distributed nationwide. For more information visit www.fda.gov.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.